Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa to Prevent Osteoporosis in Brain Tumor Patients
NCT00301873Phase 2Completed
- Sponsor
- Duke University
- Start
- May 2006
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in osteoporosis, sponsored by Duke University. Started May 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00301873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301873.